sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake Disclosure in Mural Oncology plc
The Vanguard Group, Inc. has submitted Form 8.3 under the Irish Takeover Panel rules, revealing its position in Mural Oncology plc's securities. As of 10 June 2025, Vanguard holds 773,059 of Mural Oncology's $0.01 ordinary shares, representing a 4.48% shareholding in the company.
This disclosure is made under Rule 8.3 of the Irish Takeover Panel Act, 1997. The Vanguard Group did not report any connections with other offerors or offerees, and no additional disclosures were made regarding other parties' securities.
Recent transactions included the purchase of 176 and sale of 32 Mural Oncology shares at $2.55 per unit. No cash-settled or stock-settled derivatives transactions were disclosed. There are no indemnity agreements or arrangements related to Mural Oncology's securities.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.